TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Vaccinova AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
6,233
|
3,392
|
2,653 |
Financial expenses |
1
|
2
|
1 |
Earnings before taxes |
640
|
-53
|
62 |
EBITDA |
660
|
-37
|
73 |
Total assets |
1,248
|
525
|
477 |
Current assets |
1,157
|
461
|
432 |
Current liabilities |
586
|
370
|
248 |
Equity capital |
659
|
153
|
214 |
- share capital |
5
|
4
|
5 |
Employees (average) |
35
|
25
|
20 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
52.8%
|
29.1%
|
44.9% |
Turnover per employee |
178
|
136
|
133 |
Profit as a percentage of turnover |
10.3%
|
-1.6%
|
2.3% |
Return on assets (ROA) |
51.4%
|
-9.7%
|
13.2% |
Current ratio |
197.4%
|
124.6%
|
174.2% |
Return on equity (ROE) |
97.1%
|
-34.6%
|
29.0% |
Change turnover |
2,831
|
955
|
1,475 |
Change turnover % |
83%
|
39%
|
125% |
Chg. No. of employees |
10
|
5
|
15 |
Chg. No. of employees % |
40%
|
25%
|
300% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.